Not everyone with ADHD is a candidate for stimulant medications—some have contraindications, abuse histories, or simply don't tolerate them. Non-stimulant options like Strattera and Wellbutrin provide effective alternatives. Understanding how they compare helps you and your psychiatrist navigate ADHD treatment when stimulants aren't appropriate.
Why Non-Stimulants Matter
While stimulants are highly effective for ADHD, some patients can't take them due to cardiovascular disease, seizure history, untreated hypertension, or previous substance abuse. Additionally, some people simply respond better to non-stimulants. Others want to avoid the Schedule II controlled substance designation. For these patients, non-stimulant alternatives like Strattera and Wellbutrin are valuable options.
Strattera (Atomoxetine)
Strattera is the FDA-approved non-stimulant for ADHD. It's a selective norepinephrine reuptake inhibitor (NRI) that increases norepinephrine availability in the brain, improving focus, attention, and impulse control. Strattera takes 2–4 weeks to reach full effect—slower than stimulants but achievable. Initial side effects (nausea, dizziness) often resolve as your body adjusts. Dosing starts low and titrates over weeks to an optimal level.
Wellbutrin (Bupropion)
Wellbutrin is an antidepressant (NDRI—norepinephrine-dopamine reuptake inhibitor) FDA-approved for depression. It's used off-label for ADHD, particularly in patients with comorbid depression or anxiety. Wellbutrin increases both norepinephrine and dopamine, producing benefits for mood, motivation, and attention. Like Strattera, it takes weeks to work fully. Some patients find Wellbutrin's "activating" profile preferable for ADHD; others find it too stimulating.
Onset and Timeline
Strattera reaches therapeutic levels within 4–6 weeks of consistent dosing. Wellbutrin similarly takes 4–6 weeks for full benefit. Neither works as quickly as stimulants (which work within hours), but both provide sustained improvement over time. If you need immediate symptom relief, stimulants or a short-term benzodiazepine bridge might be necessary during the wait period.
Efficacy for ADHD
Strattera is specifically FDA-approved for ADHD in both children and adults. Research demonstrates efficacy comparable to stimulants for many patients. Wellbutrin's ADHD benefits are documented but off-label. Some psychiatrists prefer Strattera for pure ADHD without mood concerns; others choose Wellbutrin when depression or low motivation accompanies ADHD.
Side Effects and Tolerability
Strattera commonly causes nausea, dizziness, fatigue, and decreased appetite—especially initially. Mood changes, including mood swings or emotional lability, can occur. Most side effects are dose-dependent and improve with dose reduction or time. Wellbutrin's side effects include insomnia, activation (jitteriness), headaches, and dry mouth. Some patients find Wellbutrin's profile easier to tolerate than Strattera's; others prefer Strattera.
Cardiovascular and Safety Considerations
Neither Strattera nor Wellbutrin increases heart rate or blood pressure like stimulants do, making them safer for patients with cardiac disease or hypertension. However, Strattera can raise blood pressure in some patients, so monitoring is still recommended. Wellbutrin lowers seizure threshold (similar to all antidepressants), so seizure history is a concern. Neither is contraindicated in cardiac disease, but individual assessment is necessary.
Abuse Potential
Neither Strattera nor Wellbutrin is controlled substances, eliminating abuse potential entirely. They can't be "abused" for a high, making them ideal for patients with addiction vulnerabilities or who are uncomfortable with Schedule II medications.
Which Should You Choose?
Choose Strattera if you have pure ADHD without mood concerns and want the most established non-stimulant option. Choose Wellbutrin if you have comorbid depression or low motivation alongside ADHD, or if you prefer its activation profile. Some patients try both before finding the better fit. Unlike stimulants with their rapid onset, non-stimulants require patience—you won't know if they work for you until after 6–8 weeks at adequate dose.
Frequently Asked Questions
Is Strattera less effective than stimulants?
Research shows comparable efficacy for many patients. However, some respond better to stimulants. The best medication is the one that works for your individual brain chemistry—non-stimulants work just as well for the right person.
Can I combine Strattera and Wellbutrin for ADHD?
Some psychiatrists use both together for treatment-resistant ADHD, though this is less common. The combination adds different mechanisms (norepinephrine alone vs. norepinephrine-dopamine), which can enhance response. Your psychiatrist will determine if this approach suits your situation.
What if non-stimulants don't work?
If both Strattera and Wellbutrin fail, your psychiatrist may reconsider stimulants with appropriate cardiac monitoring, try other non-stimulants, or explore combination approaches. ADHD treatment sometimes requires creativity and persistence.
When to See a Psychiatrist
If ADHD is affecting your work, relationships, or daily functioning—and stimulants aren't an option—a psychiatric evaluation can determine if Strattera, Wellbutrin, or another non-stimulant medication is right for you.
Talk to Next Step Psychiatry
At Next Step Psychiatry in Lilburn, GA, Dr. Aneel Ursani and Fathima Chowdhury, PA-C have extensive experience with non-stimulant ADHD treatment. Whether you need Strattera, Wellbutrin, or other options, we'll work with you to find effective management that fits your medical and personal needs.
4145 Lawrenceville Hwy STE 100, Lilburn, GA 30047 • 678-437-1659 • Schedule an appointment
This article is for informational purposes only and should not replace a consultation with a licensed mental health professional. Always consult with your psychiatrist before starting, stopping, or switching medications.